NPI: 1003870130 · LAKEWOOD, WA 98499 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 04/14/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 04/14/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 25,650 | $542K |
| 2019 | 25,155 | $608K |
| 2020 | 25,478 | $667K |
| 2021 | 25,590 | $732K |
| 2022 | 30,538 | $637K |
| 2023 | 16,057 | $789K |
| 2024 | 6,220 | $691K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 59,070 | 4,190 | $4.33M |
| A4657 | Syringe, with or without needle, each | 4,385 | 2,506 | $204K |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 44,711 | 2,154 | $63K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,134 | 512 | $56K |
| J1756 | Injection, iron sucrose, 1 mg | 11,249 | 2,388 | $9K |
| J1270 | Injection, doxercalciferol, 1 mcg | 18,175 | 1,310 | $805.50 |
| 90674 | 194 | 148 | $469.48 | |
| 90670 | 19 | 13 | $246.13 | |
| G0008 | Administration of influenza virus vaccine | 215 | 173 | $110.21 |
| 0001A | 20 | 17 | $60.24 | |
| G0009 | Administration of pneumococcal vaccine | 41 | 29 | $31.30 |
| 82728 | 1,508 | 992 | $0.00 | |
| 83550 | 1,272 | 886 | $0.00 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 1,790 | 660 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 678 | 441 | $0.00 |
| 90677 | 23 | 17 | $0.00 | |
| 83970 | 2,183 | 1,470 | $0.00 | |
| 85048 | 2,612 | 1,822 | $0.00 | |
| 85041 | 2,621 | 1,827 | $0.00 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 173 | 24 | $0.00 |
| 83540 | 1,543 | 1,013 | $0.00 | |
| 90662 | 13 | 12 | $0.00 | |
| 90661 | 15 | 13 | $0.00 | |
| 82108 | 737 | 491 | $0.00 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 292 | 52 | $0.00 |
| 0002A | 15 | 13 | $0.00 |